Market Value1,084,777,000
Total Holdings41
File Date2019-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
KDNY / Chinook Therapeutics Inc
IRWD / Ironwood Pharmaceuticals, Inc.
FGEN / FibroGen, Inc.
GILD / Gilead Sciences, Inc. Call
NKTR / Nektar Therapeutics Call
US16706W1027 / Chiasma Inc
KZR / Kezar Life Sciences, Inc.
VCEL / Vericel Corporation
ONTX / Onconova Therapeutics, Inc.
FGEN / FibroGen, Inc. Call
SNNA / Sienna Biopharmaceuticals, Inc.
CORT / Corcept Therapeutics Incorporated
HARP / Harpoon Therapeutics, Inc.
FGEN / FibroGen, Inc. Put
US2103731061 / Constellation Pharmaceuticals Inc
RYTM / Rhythm Pharmaceuticals, Inc.
DRNA / Dicerna Pharmaceuticals Inc
SLDB / Solid Biosciences Inc.
AFMD / Affimed N.V.
IRWD / Ironwood Pharmaceuticals, Inc. Call
/ Array BioPharma, Inc.
US62857M1053 / MyoKardia, Inc.
ONCE / Spark Therapeutics, Inc.
US00972L1070 / Akcea Therapeutics Inc.
RARE / Ultragenyx Pharmaceutical Inc.
CRIS / Curis, Inc.
DVAX / Dynavax Technologies Corporation
WVE / Wave Life Sciences Ltd.
MRTX / Mirati Therapeutics, Inc. Call
ACRS / Aclaris Therapeutics, Inc.
US33830X1046 / Five Prime Therapeutics Inc
IMDZ / Immune Design Corp.
RCUS / Arcus Biosciences, Inc.
SGMO / Sangamo Therapeutics, Inc.
0PP / Portola Pharmaceuticals Inc
ABUS / Arbutus Biopharma Corporation
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock) Put
MGTA / Magenta Therapeutics Inc
ASMB / Assembly Biosciences, Inc.
NLTX / Neoleukin Therapeutics, Inc.
RUBY / Rubius Therapeutics, Inc.
UBX / Unity Biotechnology, Inc.
EIGR / Eiger BioPharmaceuticals, Inc.
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
RCKT / Rocket Pharmaceuticals, Inc.
PRTA / Prothena Corporation plc
SRRK / Scholar Rock Holding Corporation
ARGX / argenx SE - Depositary Receipt (Common Stock)
PRQR / ProQR Therapeutics N.V.
CELG / Celgene Corp. Call
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock) Call
CRVS / Corvus Pharmaceuticals, Inc.
SURF / Surface Oncology Inc
IONS / Ionis Pharmaceuticals, Inc.
XNCR / Xencor, Inc.
KURA / Kura Oncology, Inc.
MRTX / Mirati Therapeutics, Inc.
ARVN / Arvinas, Inc.
CRSP / CRISPR Therapeutics AG
GOSS / Gossamer Bio, Inc.
MRSN / Mersana Therapeutics, Inc.